The level of CA 125 antigen in serum from women with uterine myoma
- 作者: Shevchukova N.F.1, Kramareva N.L.1, Kashcheyeva T.K.1
-
隶属关系:
- D.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences
- 期: 卷 48, 编号 5S (1999)
- 页面: 145-145
- 栏目: Articles
- ##submission.dateSubmitted##: 22.02.2022
- ##submission.dateAccepted##: 22.02.2022
- ##submission.datePublished##: 15.12.1999
- URL: https://journals.eco-vector.com/jowd/article/view/101425
- DOI: https://doi.org/10.17816/JOWD101425
- ID: 101425
如何引用文章
全文:
详细
Objective: The literature data on the prognostic role of blood CA 125 concentration in the patients with uterine myoma are rather different.
全文:
Objective: The literature data on the prognostic role of blood CA 125 concentration in the patients with uterine myoma are rather different.
Methods: CA 125 concentration was determined in serum samples from cubital vena and uterine vena respectively from 50 and 28 patients with uterine myoma. In the range of 0-1000 units, all assays tested correlated well with clinical findings (range of correlation coefficients 0.05 — 0.3)
Results: The CA 125 concentrations were increased in all uterine vena serum samples and were increased only in 17% of cubital serum samples.
Conclusion: We conclude that the increase of CA 125 serum level was associated with myoma necrosis, endometrial hyperplasia, intrauterine contraception usage for a long period. Moreover, the increase of CA 125 serum is an additional diagnostic test for determination of the type and time of operation.
作者简介
N. Shevchukova
D.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences
编辑信件的主要联系方式.
Email: info@eco-vector.com
俄罗斯联邦, St. Petersburg
N. Kramareva
D.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences
Email: info@eco-vector.com
俄罗斯联邦, St. Petersburg
T. Kashcheyeva
D.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences
Email: info@eco-vector.com
俄罗斯联邦, St. Petersburg
参考
补充文件
![](/img/style/loading.gif)